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HeLaThe nuclear positioning ofmammalian genes often correlateswith their functional state. For instance, the human
cystic ﬁbrosis transmembrane conductance regulator (CFTR) gene associateswith the nuclear periphery in its in-
active state, but occupies interior positions when active. Treatment with the histone deacetylase inhibitor
trichostatin a (TSA) changes the radial positioning of the CFTR gene in HeLa S3 cells. The gene relocates from
the nuclear periphery to the nuclear interior. In Calu-3 cells the gene is located in the nuclear interior. To identify
potential regulatory elements for the positioning of CFTR, the histoneH3andH4acetylation patterns of untreated
and TSA-treatedHeLa S3 and untreated Calu-3 cellswere determined by ChIP–chip. Here is a detailed description
of the datasets associated with the study byMuck et al. published in the Journal of Cellular Biochemistry in 2012.
© 2014 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).alu-3/cervix adenocarcinoma,
(male)
essed data: SOFT, MINIML,
treatment, celltypeDirect link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE29360.Experimental design, materials and methods
Cell culture
HeLa S3 and Calu-3 cells were obtained from the American Type
Culture Collection (Manassas, VA). HeLa cells were cultivated with
DMEM containing 10% fetal bovine serum. Calu-3 cells were cultivatedsity, SE-901 87 Umeå, Sweden.
This is an open access article under tas recommended. TSA (Sigma-Aldrich, Singapore) was used at a
concentration of 10 ng/ml.
Antibodies
The rabbit anti-histone H3 (ab 1791) antibody was purchased from
Abcam (Cambridge, UK).
The rabbit anti-acetyl histone H3 (06-599) and anti-acetyl histone
H4 (6-866) antibodies were purchased from Millipore (Billerica, MA).
Chromatin immunoprecipitation (ChIP)
For cross-linking chromatin immunoprecipitation (X-ChIP) the
Abcam protocol (http://www.abcam.com/index.html?pageconﬁg=
resource&rid=11698) was applied with the following modiﬁcations:
cross-linking was performed with 1.7% formaldehyde for 6 min. Cells
were lysed in RIPA buffer (150mMNaCl, 0.25% deoxycholate, 1% Triton
X-100, 50mMTris–HCl, pH 8.0) with 2mMEDTA and freshly added pro-
tease inhibitor set (complete mini, Roche, Basel, Switzerland). Chroma-
tin was sonicated with a HTU Soni 130 ultrasonic homogenizer (G.
Heinemann, Schwäbisch Gmünd, Germany). Gelelectrophoresis and
densitometric analysis revealed that ~60% of the fragments had a length
of b200 bp (~80% b1,000 bp). Immunoprecipitations were performed
overnight at 4 °C using 5 μl of the respective antibody, bound to protein
A/G Dynabeads (Invitrogen). The A/G Dynabeads were washed 3 times
using RIPA buffer, resuspended in 100 ml PBS with 10 ml 5 M NaCl-
solution, and incubated for 6 h (or overnight) at 65 °C to reverse
cross-links. DNA was puriﬁed using the Qiaquick PCR Puriﬁcation
kit (Qiagen, Hilden, Germany). Ampliﬁcation of the ChIP–DNA washe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Table 1
Data series and description ((*) indicates reverse reference).
# Series Ratio Description
1 HeLa_H3ac_532_H3pan_635_control_REP_1 532/635 HeLa untreated, H3ac/H3pan
2 HeLa_H3ac_635_H3pan_532_control_REP_2 635/532 HeLa untreated, H3ac/H3pan
3 HeLa_H3ac_635_H3pan_532_control_REP_3 635/532
4 HeLa_H3ac_635_H3pan_532_control_REP_4 635/532
5 HeLa_H3ac_532_H3pan_635_TSA_REP_1 532/635 HeLa TSA-treated, H3ac/H3pan
6 HeLa_H3ac_635_H3pan_532_TSA_REP_2 635/532 HeLa TSA-treated, H3ac/H3pan
7 HeLa_H3ac_635_H3pan_532_TSA_REP_3 635/532
8 HeLa_H3ac_635_H3pan_532_TSA_REP_4 635/532
9 Calu_H3pan_635_HeLa_H4ac_control_532_REP_2 635(#12)/635 Calu-3, H3ac/H3pan
532/532(#2) HeLa untreated, H4ac/H3pan
10 Calu_H3pan_635_HeLa_H4ac_control_532_REP_3 635(#13)/635 Calu-3, H4ac/H3pan
532(#3)/532 HeLa untreated, H4ac/H3pan
11 Calu_H3pan_635_HeLa_H4ac_control_532_REP_4 635(#14)/635 Calu-3 H4ac/H3pan
532/532(#4) HeLa untreated, H4ac/H3pan
12 Calu_H3ac_635_HeLa_H4ac_TSA_532_REP_2 635/635(#9)* Calu-3, H3ac/H3pan
532/532(#5) HeLa TSA-treated, H4ac/H3pan
13 Calu_H4ac_635_HeLa_H4ac_TSA_532_REP_3 635/635(#10)* Calu-3, H4ac/H3pan
532/532(#6) HeLa TSA-treated, H4ac/H3pan
14 Calu_H4ac_635_HeLa_H4ac_TSA_532_REP_4 635/635(#11)* Calu-3, H4ac/H3pan
532/532(#7) HeLa TSA-treated, H4ac/H3pan
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ing to the manufacturer's instructions (Sigma-Aldrich). For labeling
the Label IT mArray Labeling Kit Cy3/Cy5 (Mirus Bio LLC, Madison,
WI) was applied.
DNA microarray design
The DNA microarrays were purchased from Agilent Technologies
(Santa Clara, CA) and were designed with the software eArray
(https://earray.chem.agilent.com/erray/). Validated isothermal probes
within base pairs 116,200,000–117,400,000 (human genome assembly
hg18) of human chromosome 7were selected and a set of 9968 individ-
ual probes was obtained. Each chip contained four identical sectors and
each sector contained four identical individual probe sets. In addition,
each sector contained the (−) 3xSLv1 control set of probes and other
controls. The design ﬁle can be found here: http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GPL13608.
Hybridization was performed according to the manufacturer's in-
structions using the Stabilization and Drying kit (Agilent Technologies).
Experimental setup
ChIP of histone H3ac and H4ac and the reference ChIP of histone
H3pan for each condition and cell type were performed in parallel,
using the same chromatin. Ampliﬁed DNA samples derived from the
same experiment were hybridized on the same 4x44K microarray (the
microarray is indicated by the index “_REP_ ()” in the series record).
In case of HeLa cells, DNA derived from the histone H3ac and H3pan
ChIP was hybridized on the same sectors. DNA samples derived from
the histone H4ac ChIP were hybridized on different sectors on the
same array (using the same labeling dye as for their respective histone
H3pan reference sample). For Calu-3 cells, DNA samples derived from
the histone H3ac and H4ac ChIP were hybridized on separate sectors
on the same array as their respective histone H3pan reference (using
the same labeling dye in all cases).
Raw data extraction
DNA microarrays were scanned with an Axon Genepix 4200AL
Scanner (Molecular Devices, Sunnyvale, CA) using the software Genepix
Pro 6.0 at a resolution of 10 μm. Averaging was set to 2. For background
estimation the (−) 3xSLv1 probes were used. For each probe the back-
ground was calculated by averaging the signal intensity of the 3 closest
(−) 3xSLv1 probes (local background method).Rawdataﬁleswere deposited in theGene ExpressionOmnibus data-
base (GEO; [2]) and can be found here: http://www.ncbi.nlm.nih.gov/
geo/download/?acc=GSE29360&format=ﬁle&ﬁle=GSE29360%5FRA
W%5FGPR%5FFILES%2Etar%2Egz.
To calculate the enrichment levels, the extracted RAW data ﬁles
were combined according to Table 1.
Data analysis
For quality control, probes that failed to meet the following criteria
were “ﬂagged” and excluded from further analysis: (1) Signal to noise
ratio above 3 for both channels (Genepix Pro calculates noise as the
standard deviation of the background pixels); (2) less than 10% of pixels
saturated; (3) mean pixel intensity less than 1.2 times themedian pixel
intensity. The mean intensities of the four technical replicates (per
array) of each probe were averaged.
ChIP–chip data were analyzed using the Microsoft Excel add-in
Macro ChIPOTle [3]. The algorithm is based on a relatively simple
model, assuming relatively few regions with relevant enrichment. Low
levels of enrichment aremodeled as “noise” and should follow a lognor-
mal distribution. Quantile–quantile (Q–Q) plots were generated as de-
scribed (http://lieblab.bio.unc.edu/ChIPOTle/ChIPOTle_Readme_v1.0.
pdf) in order to determine whether the majority of data points display
a lognormal distribution. Q–Q plots were analyzed by linear regression
analysis and in all cases a lognormal distribution for data points with
low enrichment levels was observed. For cross sector comparisons
the datasets were normalized by generating histograms of log-
transformed enrichment levels and setting the maximum of these
histograms (center of the “noise”) to zero. Datasets of the same kind
were then averaged and processed data ﬁles were deposited in GEO
under accession number GSE29360.
Statistics
Statistical signiﬁcance testing was performed on the log-
transformed datasets using the Microsoft Excel add-in Macro ChIPOTle.
The following parameters were selected: sliding window of 1000 bp,
step size of 250 bp, normal distribution and a P-value of 0.001.
qPCR validation
ChIP–chip data were validated at 63 positions using qPCR as
described in [1].
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The datasets described were generated to analyze the relation be-
tween histone acetylation and radial gene positioning of the human
CFTR locus. By monitoring local changes in histone acetylation during
the process of gene repositioning, a critical binding site and consecu-
tively a regulatory factor could be identiﬁed [1]. This is an example
of how changes in a “generic” epigenetic modiﬁcation, like histone acet-
ylation, can be used to narrow down critical binding sites and potential
regulatory factors.References
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